Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Purchase | 2024-11-22 4:03 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 107,186 | $14.21 | $1,523,620 | 69,843 (Indirect) | View |
| 2024-10-03 Purchase | 2024-10-07 4:34 pm | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 6,667 | $15 | $100,005 | 20,443 (Direct) | View |
| 2024-09-12 Purchase | 2024-09-16 5:12 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 40,000 | $15.73 | $629,117 | 925,413 (Indirect) | View |
| 2024-09-10 Purchase | 2024-09-12 5:14 pm | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 6,636 | $15.07 | $99,992 | 13,776 (Direct) | View |
| 2024-09-06 Purchase | 2024-09-10 5:00 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 44,000 | $15.25 | $671,150 | 885,413 (Indirect) | View |
| 2024-08-29 Purchase | 2024-09-03 5:31 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 40,000 | $14.92 | $596,763 | 841,413 (Indirect) | View |
| 2024-08-29 Purchase | 2024-09-03 4:27 pm | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 7,140 | $14 | $99,960 | 7,140 (Direct) | View |
| 2024-08-28 Purchase | 2024-08-30 4:16 pm | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 10,000 | $13.98 | $139,800 | 10,000 (Indirect) | View |
| 2024-08-22 Purchase | 2024-08-26 4:26 pm | Inhibrx Biosciences Inc. | INBX | FORSYTH DOUGLAS Director | 75,000 | $13.83 | $1,037,328 | 224,564 (Indirect) | View |
| 2024-08-20 Purchase | 2024-08-22 4:29 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 40,000 | $12.96 | $518,282 | 801,413 (Indirect) | View |
| 2024-06-05 Purchase | 2024-06-07 6:05 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 57,549 | $17.32 | $997,024 | 1,150,410 (Indirect) | View |
| 2024-05-31 Purchase | 2024-06-04 5:27 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 286,786 | $17.18 | $4,927,580 | 1,092,861 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-16 Gift | 2024-12-17 4:29 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 750,000 | $0 | 389,686 (Indirect) | View |
| 2024-12-06 Gift | 2024-12-06 4:51 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 52,000 | $0 | 1,149,046 (Indirect) | View |
| 2024-06-24 Gift | 2024-06-24 5:27 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 99,050 | $0 | 16,250 (Indirect) | View |
Ownership | 2024-06-07 4:23 pm | N/A N/A | Inhibrx Biosciences Inc. | INXB | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 0 | $0 | 2,047,397 (Indirect) | View |
| 2024-05-29 Other | 2024-05-31 4:30 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Inhibrx Inc. 10% Owner | 13,316,140 | $0 | 14,474,066 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:11 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Vuori Kristiina MD Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:11 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | MANHARD KIMBERLY Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:10 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Lappe Mark Chief Executive Officer | 1,061,413 | $0 | 314,865 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:10 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Kayyem Jon Faiz Director | 842,325 | $0 | 36,250 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:10 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | FORSYTH DOUGLAS Director | 179,564 | $0 | 179,564 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:09 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Eckelman Brendan P. Chief Scientific Officer | 648,888 | $0 | 215,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:09 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Deck Kelly Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
Ownership | 2024-05-24 4:44 pm | N/A N/A | Inhibrx Biosciences Inc. | INXB | Inhibrx Inc. 10% Owner | 0 | $0 | 100 (Direct) | View |